NAUT Nautilus Biotechnology, Inc.
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1808805 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY6.7%
TTM EPS YoY8.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-41.0%
ROA-33.5%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets21.7%
Debt / equity0.00x
Current ratio9.25x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.90x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $234,000 | $190,000 | — | — | $0 | $0 | — | — |
| Cost of revenue | $24,000 | $15,000 | — | — | $0 | $0 | — | — |
| Gross profit | $210,000 | $175,000 | — | — | $0 | $0 | — | — |
| R&D expense | $10.18M | $9.61M | $9.71M | $9.57M | $9.61M | $10.39M | $11.54M | $12.82M |
| SG&A expense | $6.77M | $6.33M | $6.42M | $5.85M | $5.87M | $6.70M | $7.31M | $7.16M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$15.64M | -$14.47M | -$14.70M | -$13.78M | -$13.57M | -$15.03M | -$16.61M | -$17.59M |
| EPS (basic) | -0.12 | -0.11 | -0.12 | — | -0.11 | -0.12 | -0.13 | — |
| EPS (diluted) | -0.12 | -0.11 | -0.12 | — | -0.11 | -0.12 | -0.13 | — |
| Weighted avg. shares (diluted) | 127.24M | 127.14M | 126.63M | — | 126.31M | 126.20M | 126.14M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.47M | $13.17M | $14.63M | $12.39M | $24.88M | $35.46M | $34.24M | $28.65M |
| Short-term investments | $76.11M | $70.86M | $81.24M | $91.02M | $107.55M | $113.42M | $105.57M | $102.25M |
| Inventory | $900,000 | $600,000 | $300,000 | — | — | — | — | — |
| Current assets | $90.24M | $87.63M | $98.83M | $105.96M | $134.32M | $150.72M | $141.60M | $132.83M |
| PP&E, net | $5.27M | $4.00M | $3.63M | $3.46M | $3.62M | $3.73M | $3.79M | $4.08M |
| Total assets | $148.92M | $163.58M | $177.78M | $191.11M | $200.91M | $213.19M | $227.69M | $242.74M |
| Current liabilities | $9.76M | $8.64M | $8.34M | $7.95M | $8.98M | $8.14M | $8.16M | $7.63M |
| Total liabilities | $32.37M | $32.46M | $33.36M | $34.14M | $31.78M | $32.09M | $33.26M | $34.01M |
| Shareholders' equity | $116.56M | $131.11M | $144.41M | $156.97M | $169.14M | $181.09M | $194.44M | $208.73M |
| Shares outstanding | 127.33M | 127.22M | 127.07M | 126.47M | 126.31M | 126.31M | 126.15M | 126.11M |
| Cash flow statement | ||||||||
| Operating cash flow | -$13.28M | -$13.73M | -$13.10M | -$12.38M | -$11.03M | -$13.35M | -$13.94M | -$14.31M |
| Capital expenditure | $1.45M | $454,000 | $510,000 | $244,000 | $418,000 | $396,000 | $219,000 | $254,000 |
| Free cash flow | -$14.73M | -$14.18M | -$13.61M | -$12.62M | -$11.45M | -$13.75M | -$14.16M | -$14.56M |
| Investing cash flow | $10.44M | $12.02M | $14.23M | $787,000 | $452,000 | $14.47M | $19.51M | $37.11M |
| Financing cash flow | $26,000 | $244,000 | $1.10M | $101,000 | $0 | $95,000 | $18,000 | $440,000 |
| Depreciation & amortization | $200,000 | $300,000 | $334,000 | $352,000 | $400,000 | $400,000 | $465,000 | $432,000 |
| Stock-based compensation | $1.29M | $1.16M | $1.36M | $1.47M | $1.50M | $1.71M | $2.17M | $3.12M |
Free plan shows the latest 8 periods; Pro shows all 26 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.